Detalles de la búsqueda
1.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet
; 397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
2.
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
BJU Int
; 120(5): 639-650, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28453896
3.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339115
4.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522334
5.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24581940
6.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22169269
7.
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Lancet Oncol
; 12(2): 127-36, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21236730
8.
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 113(2): 305-315, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35017008
9.
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
Eur Urol Oncol
; 4(6): 980-992, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34489210
10.
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.
J Clin Oncol
; 39(27): 3022-3033, 2021 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310202
11.
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.
Eur J Cancer
; 153: 242-256, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256319
12.
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.
Clin Transl Radiat Oncol
; 21: 77-84, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072028
13.
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
Radiother Oncol
; 142: 62-71, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767473
14.
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).
Int J Radiat Oncol Biol Phys
; 103(3): 605-617, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30528653
15.
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial.
Eur Urol
; 73(6): 968-976, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29307509
16.
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 100(5): 1179-1189, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722660
17.
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).
Radiother Oncol
; 83(1): 31-41, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17391791
18.
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.
Radiother Oncol
; 84(2): 121-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17706307
19.
Guidelines for primary radiotherapy of patients with prostate cancer.
Radiother Oncol
; 79(3): 259-69, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16797094
20.
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Eur Urol
; 69(6): 1016-25, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26707868